Skip to content

Bahia Elkamand, NP

NPI 1346754918ActiveIndividual· Nurse Practitioner, Acute Care· Sugar Land, TX

Nurse Practitioner, Acute Care (NP) in Sugar Land, Texas, licensed in TX, with an NPI issued in November 2017. Part D covered 3,540 prescriptions written in 2024, 67% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 27 companies reporting payments in 2025, $6,661 in all, mostly food and beverage.

Overview

NPI1346754918
StatusActive
Entity typeIndividual
CredentialNP
Sole proprietorYes
NPI issuedNov 18, 2017
Last updated in NPPESNov 18, 2017

Specialties and licenses

TaxonomyCodeLicenseState
Nurse Practitioner, Acute Care Primary363LA2100XAP125692TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)3,540 · 4,468 30-day fills
Patients643
Total drug cost$1,005,226
Generic share67% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$6,661 · 273 payments from 27 companies
  • 2024$4,193 · 186 payments from 16 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$6,661 · 273 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nurse Practitioner, Acute Care providers in Sugar Land

All Nurse Practitioner, Acute Care providers in Texas →